nevanac
novartis europharm limited - nepafenak - pain, postoperative; ophthalmologic surgical procedures - augnlækningar - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
opatanol
novartis europharm limited - olópatadínhýdróklóríð - konjunktarbólga, ofnæmi - augnlækningar - meðhöndlun á augnsjúkdómum og einkennum á árstíðabundinni ofnæmishálsbólgu.
emla lyfjaplástur 25+25 mg/plástur
aspen pharma trading limited - lidocainum inn; prilocainum inn - lyfjaplástur - 25+25 mg/plástur
carbocain stungulyf, lausn 10 mg/ml
aspen pharma trading limited - mepivacainum hýdróklóríð - stungulyf, lausn - 10 mg/ml
carbocain stungulyf, lausn 20 mg/ml
aspen pharma trading limited - mepivacainum hýdróklóríð - stungulyf, lausn - 20 mg/ml
carbocain adrenalin stungulyf, lausn 10 mg + 5 µg/ml
aspen pharma trading limited - mepivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg + 5 µg/ml
marcain stungulyf, lausn 2,5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 2,5 mg/ml
marcain stungulyf, lausn 5 mg/ml
aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml
xylocain hlaup 20 mg/g
aspen pharma trading limited - lidocainum hýdróklóríð - hlaup - 20 mg/g
xylocain smyrsli 50 mg/g
aspen pharma trading limited - lidocainum inn - smyrsli - 50 mg/g